: Solid organ transplantation is the best therapeutic option for patients with end-stage organ disease and, according to the data from international registries, there has been a steady increase in numbers and results. However, post-transplant infections remain a fearsome complication with, in the last decade, an increasing incidence of episodes due to antibiotic-resistant bacteria and opportunistic agents. In this paper, we summarize the most relevant and updated knowledge concerning infections from multidrug-resistant germs in solid organ transplant recipients, focusing on risk factors, treatment and prevention strategies, and antimicrobial pharmacokinetics relevant to this particular population of patients.
|Autori:||Bezinover, Dmitri; Biancofiore, Gianni; Falcone, Marco; Karvellas, Costantine; Husain, Shaid; Saner, Fuat H|
|Titolo:||Multidrug-resistant infections in solid organ transplant recipients: a focus on risk factors, prevention and treatment strategies|
|Anno del prodotto:||2020|
|Digital Object Identifier (DOI):||10.23736/S0375-9393.22.16124-9|
|Appare nelle tipologie:||1.1 Articolo in rivista|